Search Results - "Pankras, C."

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
  2. 2

    Effect of abiraterone acetate plus prednisone on the QT interval in patients with metastatic castration-resistant prostate cancer by Tolcher, A. W., Chi, K. N., Shore, N. D., Pili, R., Molina, A., Acharya, M., Kheoh, T., Jiao, J. J., Gonzalez, M., Trinh, A., Pankras, C., Tran, N.

    Published in Cancer chemotherapy and pharmacology (01-08-2012)
    “…Purpose Abiraterone is the active metabolite of the pro-drug abiraterone acetate (AA) and a selective inhibitor of CYP17, a key enzyme in testosterone…”
    Get full text
    Journal Article